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Abstract. Retinoic acid (RA) has been shown to have 
variable effects on myogenic differentiation in cell cul- 
ture. The application of RA on primary cultures of em- 
bryonic somites, limb buds, and neonatal limbs inhib- 
ited myogenic differentiation in a dose-dependent way 
as indicated by the repression of: (a) myotube forma- 
tion, (b) myosin heavy chain protein accumulation, (c) 
myosin light chain (MLC) 1/3, Ctsk-actin and myogenic 
factor transcript expression. Expression of retinoic acid 
receptors (RAR) was also affected by RA treatment, 
specifically RARe/transcripts were induced. To further 
understand the pleiotropic action of RA on myogene- 
sis, we took advantage of two muscle-specific transgene 
markers which consisted of CAT reporter genes driven 
by regulatory elements either from the myosin light 
chain 1/3 locus (MLC-CAT) or the a-skeletal actin 
gene (oqk actin-CAT). RA inhibited MLC-CAT trans- 
gene but not ask actin-CAT transgene expression in pri- 
mary cultures from these mice. Analysis of MLC-CAT 
expression in transgenic mouse primary cultures and in 
stably transfected C2C12 ceils demonstrated that repres- 
sion of MLC-CAT activity by RA was dependent upon 
diffusible factors in chick embryo extract. We hypothe- 
size that during development, the pleiotropic effects of 
RA on myogenesis do not depend solely on the distri- 
bution and concentration of RA itself, but are also in- 
fluenced by extracellular signals in the embryonic envi- 
ronment. 
ORING development the actions of signaling  mole- 
cules are required to instruct individual cells when 
and where to differentiate into their ultimate tis- 
sue type. Retinoic acid (RA)  1 has long been known to af- 
fect pattern formation in vertebrate embryos (reviewed in 
Summerbell and Maden, 1990). RA treatment causes per- 
turbation  of segment  identity  along  the  anteroposterior 
(AP) body axis (Kessel and Gruss, 1991; Kessel, 1992) and 
alteration of limb morphogenesis (Tickle et al., 1982). Re- 
cent evidence has indicated that Henson's node, a pattern- 
organizing  region  at  the  anterior  end  of the  primitive 
streak in early embryos (Waddington,  1932; Beddington, 
1994) may be an endogenous source of RA (Hogan et al., 
1992). 
Given the dramatic phenotypic effects of RA on devel- 
oping embryos, it has been of interest to investigate the 
nature of its action on specific cell types, such as skeletal 
muscle precursors.  RA induces myogenic differentiation 
of a rat rhabdomyosarcoma-derived cell line,  presumably 
through induction of myogenin (Arnold et al., 1992). RA 
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has also been reported to induce myogenic differentiation 
of C2 myoblast cells  and primary  adult chicken  satellite 
cells  (Albagli-Curiel  et  al.,  1993; Halevy  and  Lerman, 
1993). However, depending on its concentration RA has 
been shown to  either  activate  or repress  myogenesis in 
both craniofacial mesenchyme (Langille et al., 1989) and 
in limb buds in early chick development (Momoi et  al., 
1992). 
To further understand the pleiotropic effects of RA on 
myogenesis and the mechanism underlying its action, we 
took advantage of two lines of transgenic mice, carrying 
the  chloramphenicol  acetyl  transferase  (CAT)  reporter 
gene under the control of the regulatory elements either 
from the rat myosin light chain (MLC) 1/3 or chicken ask 
actin  locus.  Both  transgenes  (MLC-CAT  and  cqk actin- 
CAT) are expressed in a strict muscle-specific pattern in 
mice  (Rosenthal  et  al.,  1989; Petropoulos  et  al.,  1989), 
which reflects the control of the endogenous loci in vivo 
(Sassoon et al., 1988; Lyons et al., 1990) and in tissue cul- 
ture  (Donoghue  et  al.,  1988; Wentworth  et  al.,  1991; 
Bergsma et al.,  1986). However, the regulatory elements 
included in the transgenes do not appear to be controlled 
by the same pathways in cultured muscle cells: activity of 
MLC-CAT Constructs  is dependent  upon multiple  myo- 
genic factor binding sites (E boxes) in the MLC enhancer 
(Rosenthal et al., 1990; Wentworth et al.,  1991) whereas 
mutation of the single E box in the promoter of the oqk ac- 
tin-CAT  construct  has  no  effect  on  promoter  activity 
(Chow and Schwartz,  1990). 
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mary cultures of limb buds, neonatal limbs, and somites 
from MLC-CAT and ask actin-CAT mice. RA repressed 
myogenic differentiation in a dose-dependent way, and in- 
hibited myogenic factor gene expression. In contrast to the 
MLC-CAT transgene, ctsk actin-CAT transgene expression 
was not inhibited by RA in these primary cultures, pre- 
sumably because the activation of the Cqk actin-CAT con- 
struct is  independent of myogenic factors.  Interestingly, 
RARe/transcripts were significantly induced by RA treat- 
ment. Further, repression of muscle-specific genes by RA 
was  dependent  on  culture  conditions.  Taken  together, 
these results suggest that the pleiotropic action of RA on 
myogenesis depends not only on the distribution and con- 
centration of RA itself, but is also significantly influenced 
by diffusible molecules. 
Materials and Methods 
Transgenic Mouse Lines 
The MLC-CAT transgenic mouse line used in this study (line 7), carrying 
multiple copies of a 1200-bp  rat MLC1 promoter-CAT transgene driven 
by the downstream 920-bp MLC enhancer, was generated and character- 
ized as described previously (Donoghue  et  al.,  1988; Rosenthal et  al., 
1989). Line 7 was bred to transgenic homozygosity (Grieshammer et al., 
1992). Crosses with wild-type animals yielded heterozygous embryos and 
neonates for dissociated primary cultures. The cqk actin-CAT transgenic 
mouse line was generated with a construct containing 220 bp of the regula- 
tory elements from the chicken a skeletal actin gene (originally character- 
ized by C. Ordahl, personal communication) driving a CAT reporter gene 
(Petropoulos et al., 1989). 
Preparation of Chick Embryo Extract (CEE) 
Chick embryo extract was prepared according to established protocols (J. 
Powell, personal communication) as follows: embryos from chicken eggs 
incubated for 9 d (purchased from SPAFAS) were added to an equal vol- 
ume of Hanks balanced solution (GIBCO BRL, Gaithersburg, MD). The 
mixture was forced through a 10-ml syringe twice before freezing at -20°C 
for at least one day. Upon thawing, the mixture was repeatedly passed 
through  pipettes of progressively smaller size  until  it  could  be  easily 
passed through a Pasteur pipette. After centrifugation at 1,200 g for 30 
rain, the supernatant (chick embryo extract [CEE]) was divided into 1-mi 
aliquots and frozen. To prepare medium, frozen aliquots were thawed and 
spun for 1 min at full speed in a microcentrifuge. The supernatant was 
mixed with DME and passed through 0.22-p,m filter units. Filter-sterilized 
DME with CEE was then mixed with other components to a final concen- 
tration of 2% CEE. 
Primary Cultures 
Somite dissections and cultures were described previously (Grieshammer 
et al., 1992). Limb buds were removed from wild-type, MLC-CAT, or ask 
actin-CAT transgenic embryos at 11.5, 12.5, and 13.5 dpc, dissociated by 
passing through a flame-polished Pasteur pipette, and plated onto 35-ram 
gelatinized (1% gelatin) Primaria tissue culture dishes (Falcon Plastics, 
Cockeysville, MD), one dish per pair of limb buds. Neonatal hind legs 
from  wild-type,  MLC-CAT,  or  %k  actin-CAT  transgenic  mice  were 
skinned and boned, and the dissected muscles were incubated in 0.125% 
trypsin/0.25% pancreatin in Hanks balanced solution for a total of 12 rain, 
with occasional pipetting during incubation. Cells from the dissociated 
muscles were preplated on a Falcon petri dish for 1 h to eliminate fibro- 
blasts and thereby enrich the myogenic cell population. The cells were 
subsequently plated onto 35-mm gelatinized (1% gelatin) Primaria tissue 
culture dishes, one dish per pair of hind legs. The dissociated cells were 
cultured in DME with 10% FBS (Sigma Immunochemicals), 10% horse 
serum (Sigma), 2% chick embryo extract, 2 mM glutamine, 5 U/ml penicil- 
lin G, and 5 mg/ml streptomycin sulfate at 37°C, 5% CO2. The cultures ex- 
hibited very limited growth subsequent to plating. Retinoic acid (Fluka 
Chemic AG, Buchs, Switzerland, in 100% ethanol) was added to the me- 
dium at designated days of culture, resulting in a final concentration of 10  -7 M 
or 10  -5 M. On day 4 (somite and limb bud culture) or day 6 (leg muscle 
culture) after plating, cells were fixed for histochemical staining or har- 
vested for CAT assays. Neonatal leg muscle cells used for RNA prepara- 
tions were cultured similarly as described above, but plated onto 60-mm 
plates to obtain a sufficient number of cells for RNA extraction. 
C2C12 Cell Culture, Transfections and CAT Assays 
The C~C12 cell line (Blau et al., 1983) is a subclone of the mouse skeletal 
muscle cell line C~ (Yaffe and Saxe, 1977). C~C12 myoblasts were cultured 
in growth medium (DME, with 20% FCS, 2 mM gintamine, 5 U/ml peni- 
cillin G, and 5 mg/ml streptomycin sulfate).To obtain a muscle cell line that 
stably expressed the MLC-CAT gene, C2C12 cells were plated at 2 x  105 
cells/100-mm  tissue  culture  plate  one  day  before  cotransfection with 
pMLC1CAT920 (Rosenthal et al., 1989) and pSV2neo constructs, using 
DNA-calcium  phosphate  coprecipitation (Gorman,  1985).  Transfected 
pooled clones were selected in G418 and tested for MLC-CAT reporter 
activity by CAT assays of differentiated cultures as follows: cells resistant 
to G418 were seeded at similar densities (2 ×  105 cells/100-mm tissue cul- 
ture plates or 2  x  104 cells/35-mm tissue culture plates) and fed every 
other day with growth medium or the medium specifically defined in the 
Results section. Upon confluency, which occurred three days after plating 
at the above density, the growth medium was replaced with differentiation 
medium (substitution of 2% horse serum for 20% FBS). The cells were 
fully differentiated within 48 h after the switch in medium, at which point 
they were harvested and CAT assays were performed as described previ- 
ously, normalized to total protein content (Grieshammer et al., 1992). 
C2C12-primary Cell Cocultures 
Transwell cell culture chamber inserts (Costar) were used for the cocul- 
ture experiments. Primary cells from wild-type neonatal hind leg muscles 
were plated in the upper insert chamber, and C~C12 clones stably trans- 
fected with an MLC-CAT construct (see above) were plated in the lower 
culture plate. The two cell cultures were separated by a collagen-treated 
membrane with 3.0-p.m pores. Culture medium was the same as that used 
for the primary cultures (see above). Differentiation of C2C12 cells and 
CAT assays were carded out as described above. 
RNA Isolation and Northern Analysis 
Total  RNA was  isolated by the acid guanidinium thiocyanate-phenol- 
chloroform single-step method (Chomczynski and Sacchi, 1987).  RNA 
samples were electrophoretically separated on a  formaldehyde agarose 
gel and transferred to Amersham Hybond-N nylon membrane (Sambrook 
et al., 1989). The GAPDH cDNA clone was purchased from the American 
Type Culture Collection (Rockville, MD). Other eDNA probes used in- 
cluded: mouse MLC 1/3 (Lyons et al., 1990), MyoD (Sassoon et al., 1989), 
myogenin (Sassoon et al.,  1989), human RARa (Petkovich et al., 1987), 
human RARI3 (Brand et al., 1988), human RAR't (Krust et al., 1989), and 
chicken ct skeletal actin (Petropoulos et al.,  1989). All eDNA fragments 
were labeled with  [tx32p]dCTP (DuPont-NEN,  Boston, MA) using the 
multiprime labeling kit from Amersham. Hybridization was carried out in 
5x  SSC, 50% formamide, lx  Denhardt's, and 0.1% SDS at 42°C over- 
night after prehybridization with 20  I~g/ml herring sperm DNA for 2 h. 
Blots were sequentially washed under standard conditions (Sambrook et 
al., 1989). Blots were exposed to Amersham hyperfilm-MP at -70°C with 
an enhancing screen for 2 h to 1 wk. Autoradiograms were quantitated by 
densitometry, using a computerized densitometer (Molecular Dynamics, 
Inc., Sunnyvale, CA). 
Histochemistry 
Cells  were  immunohistochemically stained  for  MHC  protein  using  a 
Vectastain ABC Kit (Vector Laboratories, Inc.). Cells were washed three 
times with PBS and incubated with 0.1% Triton in PBS for exactly I min. 
Cells were then fixed on the plates by a  20-min incubation with 100% 
methanol. After two washes with PBS containing 0.1% BSA, nonspecific 
proteins were blocked by incubation with normal horse serum for 3 min. 
Anti-MHC antibody MF20 or F59 (diluted with PBS/0.1% BSA) was then 
added onto the plates and incubated at 4°C overnight. Subsequent incuba- 
tion with biotinylated secondary antibody followed by incubation with 
Vectastain ABC reagent (a preformed avidin and biotinylated horserad- 
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standard procedures for the kit. Finally, substrate solution made from 
DAB tablets (Sigma) following  manufacturer's instructions was used to 
stain the plates for 2-7 min. The degree  of staining was recorded  with mi- 
croscopic  photography. 
Results 
Differentiation of Primary Muscle Cell Cultures Is 
Inhibited by RA 
Previous studies using various culture systems to test the 
effects of RA on myogenesis have yielded inconsistent re- 
sults.  Specifically, the  inhibition  of myogenesis by rela- 
tively high concentrations of RA in the chicken embryo 
craniofacial mesenchyme (Langille et al., 1989) and chicken 
limb bud (Momoi et al.,  1992) culture systems are in con- 
trast  with  the  induction  of myogenic differentiation by 
similar concentrations of RA reported for the C~ myoblast 
cell line (Halevy and Lerman, 1993; Albagli-Curiel et al., 
1993) and a rhabdomyosarcoma-derived cell line (Arnold 
et al., 1992). The concentration of RA used in these stud- 
ies ranged from 10-1°-10-6M, and the RA concentration 
used to induce differentiation of other malignant cell lines, 
such  as  murine  melanoma  cells,  was  as  high  as  10-SM 
(Niles,  1987).  Although  variations  in  RA  concentration 
may be responsible for some of the variability in these re- 
sults, the data relating RA concentration to myogenic in- 
duction or inhibition is still far from conclusive. 
The pleiotropic effects of RA on myogenesis were fur- 
ther examined by treating primary dissociated cultures of 
13.5 dpc mouse limb buds and neonatal hind leg muscles 
with 10 -7 and 10-5M RA. The neonatal cultures were pre- 
plated to eliminate fibroblasts and, thereby to enrich for 
myoblasts.  The  remaining  cells  underwent  very limited 
growth subsequent to dissociation. Myogenic differentia- 
tion was inhibited at both concentrations of RA tested. In 
primary cultures treated with 10-5M RA very few fused 
myotubes were present, whereas untreated cultures con- 
tained many myotubes (see Fig. 1). Since both concentra- 
tions  of RA  significantly inhibited  myogenic differenti- 
ation in the primary cultures but 10-SM RA produced a 
more dramatic effect, we  chose to perform most of the 
subsequent primary culture experiments at the higher con- 
centration, with selected duplicate  experiments at lower 
concentrations (10  -7 or 10-8M RA). 
As a  measure of RA-induced myogenic inhibition, the 
expression of a muscle-specific structural protein, myosin 
heavy chain  (MHC), was  tested by staining  the cultures 
described above with anti-MHC antibodies. Fig. 1 shows a 
dramatic  reduction  in  MHC  staining  in  the  10-SM  RA 
treated cultures. Treatment with 10-7M RA yielded simi- 
lar results (data not shown). The reduction in MHC-posi- 
tive cells in the RA-treated cultures was not due to selec- 
tive apoptosis, as determined by analysis of DNA ladders 
in  genomic  DNA  from  untreated  and  treated  cultures 
(data not shown). Thus, RA inhibits both morphological 
and  biochemical  differentiation  in  primary  muscle  cul- 
tures. 
Muscle-specific  Transcript Accumulation Is Repressed 
by RA in Primary Muscle Cultures 
To  investigate  the  potential  mechanism  underlying  the 
RA-mediated inhibition of myogenesis, we studied the ef- 
fects of RA treatment on accumulation of transcripts en- 
coding muscle-specific structural proteins. MLC  1 and 3 
are encoded in a single locus and are expressed in a differ- 
entiation-dependent manner (reviewed in Rosenthal et al., 
I992). In primary muscle cultures prepared from dissoci- 
ated neonatal mouse hind legs, MLC1/3 transcripts were 
reduced  about  10-fold upon  treatment  with  10-5M  RA 
(Fig. 2, a and b). Since MLC expression is under the con- 
trol  of myogenic factors  (Rosenthal  et  al.,  1990;  Went- 
worth et al., 1991) we examined whether the relative levels 
of myogenic factor transcripts were changed in these cul- 
tures. MyoD and myogenin transcripts were reduced 5- tO 
10-fold by RA treatment (Fig. 2, a  and b), whereas tran- 
scripts encoding Myf5 or MRF4 were not detected in ei- 
Figure l.  Inhibition  of myo- 
sin heavy chain protein accu- 
mulation by RA treatment of 
primary muscle cultures. 13.5 
dpc limb buds  and newborn 
leg muscles were dissociated 
and  cultured  +10-SM RA. 
Cultures  were  immunohis- 
tochemically stained  for my- 
osin heavy chain using anti- 
MHC  antibodies  F59  (13.5 
dpc) or MF20 (neonatal). 
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cle-specific transcripts  in RA 
treated  primary  cultures. 
RNA was isolated  from neo- 
natal leg muscles dissociated 
and cultured  in the presence 
or absence of RA and ana- 
lyzed  by Northern blots us- 
ing  probes  as  indicated.  A 
GAPDH  probe  was  in- 
cluded  to  control  for  equal 
RNA  loading.  (a)  Northern 
analysis of MyoD, myogenin 
and  MLC1/3  transcripts  -+ 
10-SM RA.  Blots  were  also 
probed for Myf5 and MRF4 
but  no  signal  was  detected 
(data not shown).  (b) Histo- 
gram showing the relative in- 
tensity of the autoradiographic 
bands  in  a.  Densitometric 
scans of the autoradiographs 
were normalized to the values obtained for GAPDH. All data points are averages of three independent experiments (with standard er- 
ror). Data are presented as percentages of untreated controls which were arbitrarily set at 100. (c) Northern analysis of cq  k actin tran- 
scripts -+ 10~M or 10-SM RA. A GAPDH probe was included to control for equal RNA loading. 
ther untreated or treated cultures (data not shown).  It is 
therefore likely that under these conditions, the reduction 
in MLC transcripts  is mediated by a  concomitant reduc- 
tion in MyoD and/or myogenin. 
We next examined the effects of RA treatment on the 
expression  of  ask  actin,  another  structural  gene  whose 
activation  in  skeletal  muscle  is  under  the  control  of  a 
combination of positive and negative factors, distinct from 
the  MyoD  family  of  myogenic  regulators  (Chow  and 
Schwartz,  1990).  As seen in Fig. 2 c, ask actin transcripts 
were dramatically reduced in the presence of either 10  -8 
or 10-SM RA. Thus it appears that multiple components 
of the myogenic program are affected by RA treatment. 
RA Inhibits Expression  of the MLC-CAT Transgene 
but Not the ask Actin-CAT Transgene 
To investigate the possibility that RA affects the expres- 
sion  of muscle-specific structural  genes  at  the  transcrip- 
tional level, we measured the effect of RA on the expres- 
sion of a transgene which is controlled by DNA regulatory 
elements known to be responsive to myogenic differentia- 
tion. Transgenic mouse lines have previously been gener- 
ated which contain promoter and enhancer elements from 
the  MLC1/3  locus  driving  the  CAT  gene  as  a  reporter 
(MLC-CAT; Fig. 3 a). The expression of this transgene is 
muscle-specific  in  the  adult  and  during  embryogenesis 
(Rosenthal et al., 1989; Grieshammer et al., 1992). Embry- 
onic limb buds (11.5, 12.5,  and 13.5 dpc) or neonatal hind 
leg muscles from MLC-CAT transgenic mice were dissoci- 
ated and cultured with or without 10-5M RA. As shown in 
Fig. 4, MLC-CAT activity was consistently reduced 4- to 
15-fold  in  RA-treated  cultures  from  different  develop- 
mental stages as compared to untreated cultures. Since the 
enhancer  in  the  MLC-CAT  reporter  construct  contains 
myogenic factor binding sites, which  are essential for its 
transcriptional activity in tissue culture  (Rosenthal et al., 
1990; Wentworth et al., 1991), it seems likely that the RA- 
mediated inhibition of transgenic MLC-CAT activity and 
of endogenous MLC 1/3 expression occurs indirectly in re- 
sponse to a reduction of myogenic factors (Fig. 2, a and b). 
In embryonic somites, the  MLC-CAT transgene is ex- 
pressed in  a  gradient  along the  rostrocaudal  axis  of the 
embryo: low levels of CAT activity are present in the most 
mature  rostral  somites,  with  increasing  CAT  activity in 
more caudal somites as they progressively mature. Graded 
transgene expression is retained in dissociated somite cul- 
tures  (Grieshamer  et  al.,  1992,  Fig.  5).  When  11.5  dpc 
somites from various rostrocaudal positions were dissoci- 
ated and cultured with RA (10-SM or 5  ×  10-7M),  a  de- 
crease in CAT activity was found at both concentrations 
when compared to untreated  cultures  (Fig. 5). These re- 
suits show that RA inhibits myogenesis in all developing 
somites, independent of their maturity status, and that RA 
treatment  does  not  change  the  graded  CAT  expression 
profile in these tissues. 
In contrast to the cis-acting DNA sequences used for the 
generation  of the  MLC-CAT  transgene,  muscle-specific 
regulatory elements isolated from the 5' end of the ask ac- 
tin gene (Fig. 3 b) do not depend on myogenic factor bind- 
ing sites for their activity in muscle tissue culture  (Chow 
and Schwartz, 1990).  Since the endogenous gene is respon- 
sive  to  RA  (Fig.  2  c),  we  examined  the  regulation  of a 
transgene  containing  a  CAT  gene  reporter  driven  by a 
220-bp  ask actin  promoter fragment  (Petropoulos  et  al., 
1989).  Primary cultures  were  prepared  from dissociated 
ask actin-CAT transgenic limb buds (12.5  and 13.5 dpc) or 
neonatal hind leg muscle, and maintained with or without 
10-SM RA. In contrast to the response of the endogenous 
ask actin locus, expression of the ask actin-CAT transgene 
was not inhibited but rather was induced up to threefold 
by RA at all developmental stages (Fig. 6). Thus it appears 
that the 220-bp actin promoter fragment used in the trans- 
genic mice lacks regulatory elements present elsewhere in 
the endogenous ask actin gene locus that mediate inhibi- 
tion of actin expression by RA. 
The Journal of Cel| Biology, Volume 129, 1995  1348 Figure 3. CAT constructs used 
for  the  generation of trans- 
genic  mice.  (a)  The  MLC- 
CAT transgene. Construction 
of the  transgene and gener- 
ation of transgenic mice has 
been described (Rosenthal et 
al., 1989). Protein binding  sites 
in the rat MLC enhancer in- 
clude a putative Hox binding 
site, an E box that binds Zbul, 
a  member  of  the  SWI/SNF 
family  of  transcription  fac- 
tors  (unpublished data),  two 
E  boxes (A and C) that bind 
myogenic factors (Rosenthal 
et al., 1990; Wentworth et al., 
1991), a CArG box (Ernst et 
al., 1991), a fourth E box that 
binds the bHLH factor AP4 
(unpublished), and  a  MEF2 
binding site  (Gossett  et  al., 
1989). (b) The cq  k actin-CAT 
transgene. Construction of the 
transgene and generation of 
transgenic mice has been de- 
scribed  (Petropoulos  et  al., 
1989).  Protein  binding sites 
in the ask actin promoter in- 
clude three SRF binding sites, 
a  YY1  binding site,  and  a 
TEF1 binding  site (Gualberto 
et  al.,  1992  and  C.  Ordahl, 
personal communication). 
Figure 4.  Inhibition of MLC- 
CAT  transgene  expression 
by RA treatment of limb bud 
and limb muscle primary cul- 
tures  from  different  stages. 
Primary  cultures  from  11.5, 
12.5, and 13.5 dpc limb buds 
and neonatal leg muscles of 
MLC-CAT  transgenic  mice 
were treated with 10-5M RA 
at  different times after plat- 
ing as  indicated.  Cells were 
harvested 4 d (11.5-13.5 dpc) 
or 5 d (neonatal)  after plating 
and  CAT  assays  were  nor- 
realized  to  protein  content. 
CAT  activity  in  untreated 
cultures increased during de- 
velopment in an approximate 
ratio  of  1(12.5  dpc):5(13.5 
dpc):lOO(neonatal).  Values are averages of three independent experiments (with standard error) except the columns marked *, which 
are an average of two experiments. Data are presented as percentages of untreated controls which were arbitrarily set at 100. 
Xiao et al. RA Inhibits Myogenesis  1349 Figure 5.  Inhibition of MLC-CAT transgene expression by RA treatment of 11.5 dpc somite primary cultures. Triplicate cultures were 
prepared from pooled five-somite  sections  isolated  from six 11.5 dpc MLC-CAT transgenic  embryos as described  in Materials  and 
Methods. The most rostral somite sections (1-5) are shown to the left and the most caudal somite sections (26-30) are shown to the right 
in each panel. 10-SM RA (middle) or 5 ×  10-7M RA (right) were added to the cultures  directly after plating. Cells were harvested for 
CAT assays 3 d after plating. CAT assays were normalized to protein content for each triplicate set of cultures and are shown relative to 
the highest value in the untreated somite cultures (set to 100). CAT activity in these triplicate untreated cultures varied less than three- 
fold. Values are averages of three independent experiments (with standard error), except for the columns marked * which are an aver- 
age of two experiments. 
Retinoic Acid Receptor Gene Transcripts Are Regulated 
by RA in Primary Cultures 
The  action  of RA  on  gene  expression  involves  at  least 
three nuclear RA receptors (RAR), RAR a  (Gigure et al., 
1987; Petkovich et al., 1987; Zelent et al., 1989), [3 (de The 
et al., 1987; Benbrook et al., 1988; Brand et al., 1988; Ze- 
lent, et al., 1989),  and ~/(Krust et al., 1989;  Zelent et al., 
1989).  The RAR genes are differentially expressed during 
development and regulated by RA (de The et al., 1989). 
To investigate the possible involvement of RARs in RA- 
mediated repression of myogenesis in cell culture, we ex- 
amined the effect of RA on RAR gene expression in pri- 
mary cultures prepared from nontransgenic neonatal hind 
limb muscles. As shown in Fig. 7, both RARa and ~/tran- 
scripts were expressed at low levels and RARI3 transcripts 
were almost undetectable in untreated cultures. In response 
to RA treatment, RAR[3 and RAR~ transcript levels were 
greatly increased,  while  levels  of  RARtx  transcripts  re- 
mained unchanged. The differential accumulation of spe- 
cific RAR transcripts in response to RA suggests that they 
might be involved in mediating the effect of RA on myo- 
genesis in these primary cultures. 
Inhibition  of  Myogenesis by RA Is Dependent on 
Diffusible  Factors 
The results described above show that RA treatment re- 
presses the  myogenic program in  primary cultures.  This 
contrasts with the induction of myogenesis in response to 
RA that has been reported for the C2 myogenic cell line 
and  for  primary  adult  chicken  satellite  cells  (Albagli- 
Curiel et al., 1993; Halevy and Lerman, 1993).  To resolve 
the apparent discrepancy between these studies, we exam- 
ined the response of the myogenic cell line C2C12 to RA 
under different culture conditions. C2C12 cells were stably 
transfected  with  the  same  construct  used  for generating 
MLC-CAT transgenic mice (Fig. 3). These cultures (C2C12/ 
MLC-CAT)  were  differentiated  in  the  absence  or pres- 
ence of RA. Treatment with 10-SM RA resulted in a mod- 
est twofold reduction in CAT activity (Fig. 8, left), consid- 
erably less than the inhibition of the same construct in the 
transgenic primary culture system (Fig. 4). No change in 
endogenous MLC or myogenin expression levels was seen 
in the RA-treated C-~C12 cells (data not shown), suggesting 
that the C2C12 line is much less responsive to RA than are 
primary muscle cultures. 
To determine whether the response of CzC12 cells to RA 
could  be  affected  by  coculture  with  primary  cells,  we 
prepared a mixed culture of C2C12/MLC-CAT stable trans- 
fectants and primary neonatal muscle cells from nontrans- 
genic mice. Expression of the  CAT reporter, now exclu- 
sively contributed  from  C2C12 cells,  was  reduced  about 
fivefold in response to 10-5M RA (data not shown). The 
two  populations  of cells were  then  cultured  in  separate 
chambers, allowing diffusion of media components, to in- 
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RA in the C2C12 background was due to diffusible factors 
produced by the primary ceils. Fig. 8 (right) shows that in 
these separated cocultures, C2C12 transfectants responded 
to 10-5M RA with a fivefold repression of MLC-CAT ac- 
tivity.  As  a  negative  control,  CEC12/MLC-CAT transfec- 
tants were cocultured  with untransfected  C2C12 cells, re- 
placing primary cells in the second chamber. CAT activity 
was  reduced  no  more  than  twofold  in  response  to  RA 
treatment (data not shown). 
Since  different  media  were  routinely  used  to  culture 
C2C12 and primary cells (specifically the inclusion of CEE 
in primary cultures) it was important to determine whether 
Figure  7.  Expression of RAR transcripts  in neonatal leg muscle 
primary cultures.  RNA was isolated from neonatal leg muscles 
dissociated  and cultured -  10-5M RA and analyzed by Northern 
blots  hybridized  with  RARet,  ~,  and  ~  probes  as  indicated. 
GAPDH and MLC1/3 probes were included to control for equal 
RNA  loading  and  myogenic differentiation,  respectively.  The 
panel on the right compares the relative increase in RAR ~/tran- 
scripts with the concomitant decrease in MLC1/3  transcripts  in 
the presence of RA. 
Figure  6.  Expression  of the 
eqk  actin-CAT  transgene  is 
not  inhibited  by  RA  treat- 
ment  of  primary  cultures. 
Limb  buds  from  12.5 and 
13.5 dpc ask actin-CAT trans- 
genic  embryos and leg mus- 
cles from neonatal ask actin- 
CAT  transgenic  mice  were 
dissociated  and  cultured  +_ 
10-SM RA.  Cells  were  har- 
vested 4 d (12.5 and 13.5 dpc) 
or 6 d (neonatal) after plating 
and  CAT  assays  were  nor- 
malized  to  protein  content. 
CAT  activity  in  untreated 
cultures  varied up to  three- 
fold. Values are averages of 
three  independent  experi- 
ments  (with  standard  error) 
except  for  the  column 
marked *, which is an aver- 
age of two experiments.  Data 
are presented as percentages 
of untreated  controls which 
were arbitrarily set at 100. 
culture  conditions  could affect the  response to RA.  Pri- 
mary muscle cells could not be cultured in C2C12 growth 
media, but  C2C12 cells grew normally in primary culture 
medium. We therefore analyzed the role of different com- 
ponents of the primary culture medium in determining the 
response of C2C12 cells to RA. C2C12/MLC-CAT transfec- 
tants were cultured in four different combinations of the 
primary medium components and CAT activity assayed as 
a measure of myogenic differentiation. As shown in Fig. 9, 
MLC-CAT  expression  in  C,2C12 cultures  containing  2% 
CEE  was inhibited  by RA, both at 10-8M  (2- to 3-fold) 
and 10-SM (4- to 10-fold). By contrast, MLC-CAT expres- 
sion in C2C12 cultures lacking 2% CEE was increased up to 
threefold at 10-8M concentration of RA and remained al- 
most unchanged in the presence of 10-5M RA. These re- 
sults indicate that the effects of RA upon muscle-specific 
gene  expression  are  dependent  upon  diffusible  factors 
present in the culture media. 
Discussion 
This study demonstrates that  RA inhibits myogenesis in 
mouse primary cultures  derived  from different develop- 
mental stages, as indicated by a reduction in MHC protein 
levels, in transcripts encoding endogenous MLC1/3, ask ac- 
tin and two myogenic factors, and in MLC-CAT transgene 
activity. Further,  RA-induced  inhibition  of gene  expres- 
sion in muscle cell cultures is dependent upon media con- 
ditions.  This system can  now be used  to  further  dissect 
RA-mediated regulation of gene expression, and may pro- 
vide a model for the pleiotropic functions of RA in differ- 
ent cellular contexts during embryonic development. 
The involvement of diffusible factors in modulating the 
effects of RA on myogenesis in cell culture may also re- 
solve the discrepancies seen in previous studies. Both acti- 
vation  and  repression  of myogenic differentiation  in  re- 
sponse to RA has previously been observed in myogenic 
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MLC-CAT in C2Ct2 cells. (Left) C2C~2  cells stably transfected with 
the MLC-CAT construct  (see Fig. 3) were cultured  ± 10-SM RA. 
(Right)  C2C12/MLC-CAT cells  and  nontransgenic  neonatal  leg 
muscle cells were cocultured  ± RA (concentrations  as indicated) 
in two chambers separated by a membrane that permits diffusion 
of media. All  CAT assays were normalized to protein content. 
CAT activity in untreated cultures varied no more than threefold. 
Values  are  averages of three  independent  experiments  (with 
standard error). Data are presented as percentages of untreated 
controls which were arbitrarily set at 100. 
cells (Langille et al., 1989; Momoi et al., 1992)  as well as in 
other  cell types including  the  P19  embryonic carcinoma 
cell line. At high concentrations,  RA inhibits myogenesis 
in chicken embryo craniofacial mesenchyme (Langille et 
al., 1989)  and limb buds (Momoi et al., 1992). By contrast, 
similar RA concentrations  have been reported to induce 
myogenic differentiation in a rhabdomyosarcoma-derived 
cell line (Arnold et al., 1992), in C2 myoblasts, and in pri- 
mary  adult  chicken  satellite  cells  (Albagli-Curiel  et  al., 
1993;  Halevy and  Lerman,  1993).  It is  formally possible 
that primary muscle cultures may be intrinsically different 
from tumor cell lines and nontransformed myogenic cell 
lines, most of which respond to RA with decreased growth 
rates and/or increased differentiation. Notably, neither en- 
dogenous  MLC1/3  nor myogenin transcript  levels in  the 
C2C12 cultures varied significantly under different RA con- 
centrations or culture conditions (data not shown). Never- 
theless, the results of the present study suggest that in ad- 
dition to RA concentration, culture conditions are critical 
in determining the effects of RA treatment. 
The pleiotropic effects of RA are not limited to myo- 
genic cell types. Many tumor and nontumor cell lines are 
induced to differentiate in the presence of RA. However, 
differentiation of some cell lines, such as the Ob17 murine 
preadipocyte cell line, is impaired by RA treatment (Te- 
Figure 9. Effects of culture conditions on the expression of MLC- 
CAT in RA-treated C~Clz cultures. C2C12 ceils stably transfected 
with the MLC-CAT construct  were cultured  _+ 10  -8 or 10-SM RA 
in different  media as indicated.  CAT assays were normalized to 
protein content.  CAT activity  in  untreated  cultures  varied no 
more than fivefold. Values are averages of four independent ex- 
periments (with standard error). Data are presented as percent- 
ages of untreated controls which were arbitrarily set at 100. 
boul et al., 1992) which represses adipsin gene expression 
at a posttranscriptional level (Antras et al., 1991). P19 cells 
respond to a low concentration of RA (lower than 10-8M) 
by differentiating into muscle precursors (Edwards et al., 
1983),  but  undergo  neural  differentiation  at  higher  con- 
centrations  (higher than 5  ×  10-8M; Jones-Villeneuve et 
al., 1983).  In vivo, RA administration has varying effects at 
different  developmental  stages.  For  example,  the  same 
RA dose that is highly teratogenic, disturbing segmenta- 
tion of the central nervous system when administered on 
7.5 dpc, has no obvious effects on brain development when 
administered at 8.5 dpc (Zimmer and Zimmer, 1992).  Sim- 
ilarly  the  type  of homeotic  transformation  of vertebrae 
caused  by  RA  depends  on  the  developmental  stage  at 
which embryos are treated (Kessel and Gruss, 1991; Kes- 
sel, 1992).  The present report suggests that the concentra- 
tion-dependent effects of RA are likely to be mediated by 
other  diffusible  factors,  present  at  different  times  and 
places in the developing embryo. 
The unusual RAR gene expression profiles induced by 
RA treatment of primary muscle cultures (Fig. 7) also may 
provide insight  into  the  mechanism by which  RA  func- 
tions, and into its role in the regulation of differentiation 
and development (see de Luca, 1991 for review). RNA lo- 
calization studies have shown that RARer is ubiquitously 
distributed whereas RAR[3 and RARe/transcripts are dif- 
ferentially expressed among cell lines and during develop- 
ment, suggesting that they have specific roles in different 
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effects of RA are further modulated by changes in RAR 
expression in response to RA (de The et al., 1987; Gigure 
et al., 1987; Petkovich et al., 1987; Benbrook et al., 1988; 
Brand et al., 1988; Krust et al., 1989; Zelent et al., 1989). 
The RAR[3 gene has a  RA response element that is in- 
volved in a positive auto-regulatory feedback loop (Sucov 
et al., 1990).  In most of the cell lines, the expression of 
RAR[3 is induced by RA and impairment of this induction 
may contribute to neoplastic progression (Hu et al., 1991). 
In RA-treated mid-gestation mouse embryos, RAR[3  is 
the only significantly induced RAR isoform, especially in 
limb buds (Harnish et al., 1992). The constitutive expres- 
sion of RARer and induction of RAR[3 in muscle cultures 
treated with RA observed in this study (Fig. 7) are consis- 
tent with the  RAR  expression patterns  reported  previ- 
ously. However, the significant induction of RARe/tran- 
scripts by RA as seen in the muscle cultures presented 
here (Fig. 7) has been rarely reported in the literature (Wu 
et al., 1992).  It is not clear what role RARe/may play in 
myogenic determination  during  development.  Distribu- 
tion of RAR~ transcripts during mouse embryogenesis is 
uniform before 12.5 dpc, but later becomes specifically lo- 
calized to cartilage and differentiating squamous kerati- 
nizing epithelia (Ruberte et al., 1990). The potential role 
of RAR~ in the regulation of myogenic differentiation can 
now be addressed in culture with the reagents defined in 
this study. 
At present the RA-responsive element(s) in the MLC- 
CAT transgene remain to be identified. Neither the 1200- 
bp  MLC1  promoter  or  the  920-bp  3'  MLC  enhancer 
fragments included in the transgene construct contain a 
canonical RA-responsive sequence element, suggesting that 
RA may operate through repression of upstream regula- 
tors of MLC expression, such as the myogenic bHLH fac- 
tors (see Fig. 2). Myogenic factor binding sites have been 
implicated in the transcriptional regulation of the MLC 1/3 
locus (Rosenthal et al., 1990; Wentworth et al., 1991). It is 
therefore possible that RA-responsive elements lie within 
the regulatory sequences of the myogenic factors them- 
selves.  In  contrast,  muscle-specific transcription  of  the 
MHC  and  ask  actin  gene  promoters  is  independent  of 
MyoD1  (Chow  and  Schwartz,  1990; Thompson  et  al., 
1991). Although direct regulation of these genes in vivo by 
myogenic factors is still a possibility, it is likely that path- 
ways involving other factors also mediate the effect of RA 
on muscle-specific gene expression. Notably the %k actin- 
CAT transgene represents the only muscle-specific marker 
tested in this study which was not repressed by RA (Fig. 
6). The 220-bp ask actin promoter is not dependent upon 
myogenic factor binding sites for its activity in muscle cell 
culture (Chow and Schwartz, 1990), and is highly expressed 
in proliferating myoblasts (Seiler-Tuyns et al., 1984) sug- 
gesting that it  may be  regulated  differently from other 
muscle-specific promoters. In the present study the persis- 
tent expression of the %k actin-CAT transgene serves as 
an internal control, confirming that inhibition of myogene- 
sis by RA did not result from selectively killing myogenic 
precursors in the heterogeneous cell cultures. 
The dramatic response of primary cell cultures to RA 
treatment, accompanied by a reprogramming of RAR ex- 
pression  patterns,  may provide  important  clues  to  the 
mechanism of RA action in the context of the developing 
vertebrate embryo. Retinoids are endogenously produced 
(Hogan et al., 1992),  and unevenly distributed along the 
embryonic AP  limb  and  body axes  at  early embryonic 
stages. The uneven distribution in retinoids in the embry- 
onic limb axis (Thaller and Eichele, 1987) and in the activ- 
ity of a RA response element (RARE) along the embry- 
onic body axis in RARE transgenic animals (J. Rossant 
personal  communication)  is  consistent  with  a  concen- 
tration-dependent effect on myogenesis. In the  simplest 
model, RA may play a role in preventing myogenic cells 
from differentiating until the appropriate embryonic stage 
is reached, consistent with its inhibition of myogenic dif- 
ferentiation in cell culture. 
The local extracellular environment, involving cell-cell 
interactions and diffusible molecules, is probably as im- 
portant as RA concentration in defining the effects of RA 
in the intact embryo. RA may therefore act through inter- 
mediates, such as the sonic hedgehog morphogen which 
has been implicated in patterning of both axial structures 
and limb buds in the embryo (Echelard et al., 1993; Riddle 
et al.,  1993).  In  addition, while RARo~ mRNA is ubiq- 
uitously distributed in the  embryo, transcripts  encoding 
RARI3 and RARe/each have a specifically restricted and 
dynamically changing pattern  of expression, which may 
also play an important role in modulating the effects of 
RA  both  spatially  and  temporally.  The  present  study 
should provide a valuable model for dissecting the role of 
differential RAR induction by RA in muscle differentia- 
tion, and for identifying and characterizing diffusible mol- 
ecules which may mediate the specific effects of RA on 
myogenesis, as well as on the development of other em- 
bryonic tissues. 
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